[Assessment of prognosis factors in the cure of Cushing's disease surgically treated via a +septotransphenoidal approach].
BACKGROUND
In Cushing's disease (CD) pituitary surgery or radiotherapy has been proposed by some authors, when plasmatic cortisol after surgery is not clearly low.


OBJECTIVE
To assess if the different prognostic factors, specially plasmatic cortisol seven days after surgery and/or hypocortisolism phase are predictive of the CD outcome.


METHODS
From 1988, 11 women with CD underwent 13 transsphenoidal microsurgery, because two patients relapsed. The mean age of patients was 27 years (11-52). Plasmatic cortisol was measured seven days after pituitary surgery, and since 45 days, every three-six months, basal plasmatic cortisol and after ACTH and urinary free cortisol were determined.


RESULTS
Follow-up evaluations ranged from 18-84 months (median, 38 months). After pituitary surgery in 13 cases the cumulative remission was 100%, two cases relapsed. In 10 cases plasmatic cortisol seven days after surgery was less than 137 nmol/l and in three cases higher than 137 nmol/l. Three cases did not presented hypocortisolism phase. The two patients who relapsed, one was after eight months of pituitary surgery an previously showed low plasmatic cortisol and the other relapse 25 months after pituitary surgery without low cortisol plasmatic levels.


CONCLUSIONS
Remission in CD can happen either low or normal plasmatic cortisol levels seven days posttreatment or without hypocortisolism phase. Ours findings ascribe new importance to the different presentations after treatment of CD, and patients with these findings are not a risk for relapse and pituitary surgery or irradiation would not be early indicated.
González
J D
JD
Servicio de Endocrinología y Nutrición, Ciutat Sanitària i Universitària de Bellvitge, L'Hospitalet de Liobregat, Barcelona.
Gómez
J M
JM
Montanya
E
E
Carrera
M J
MJ
Villabona
C
C
Acebes
J J
JJ
Soler
J
J
D000293:Adolescent; D000328:Adult; D002648:Child; D003480:Cushing Syndrome / Q000097:blood / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007016:Hypophysectomy / Q000379:methods*; D008875:Middle Aged; D011379:Prognosis; D012074:Remission Induction; D013100:Sphenoid Bone
D006854:Hydrocortisone